Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L7WS
|
||||
Former ID |
DIB015270
|
||||
Drug Name |
RX-3117
|
||||
Synonyms |
Antimetabolite (cancer), Rexahn; Antimetabolite (cancer), Rexahn/ Teva
|
||||
Indication | Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] | Phase 1 | [524590] | ||
Company |
Rexahn
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | DNMT1 | Target Info | Inhibitor | [532483] | |
Pathway Interaction Database | Regulation of retinoblastoma protein | ||||
PathWhiz Pathway | Methionine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.